Fatigue News and Research

RSS

New FDA approval expands use of AstraZeneca's Faslodex for women with HR+, HER2- metastatic breast cancer

AstraZeneca today announced that the US Food and Drug Administration has approved a new indication in the US, expanding the use of Faslodex (fulvestrant) to include use in combination with Ibrance (palbociclib).

7 Mar 2016

Kessler Foundation's Silvana L. Costa awarded Switzer Research Fellowship for research on MS

Silvana L. Costa, PhD, of Kessler Foundation has been awarded a Switzer Research Fellowship by the National Institute on Disability, Independent Living and Rehabilitation Research. The $70,000 Merit Award funds her research on "Processing Speed Deficits in Multiple Sclerosis: Exploring the Complex Sensorial Cognitive Motor Interaction."

7 Mar 2016

Fatigue can contribute to pitching injuries in adolescents

Shoulder and elbow injuries in adolescent pitchers are becoming more and more prevalent each year. Researchers presenting their work today at the American Orthopaedic Society for Sports Medicine’s Specialty Day, highlight how fatigue can affect pitching mechanics and potentially result in injuries.

7 Mar 2016

RUVICA (ibrutinib) capsules approved for treatment-naïve CLL patients

The U.S. Food and Drug Administration has approved IMBRUVICA (ibrutinib) capsules for treatment-naïve patients with chronic lymphocytic leukemia (CLL).

4 Mar 2016

Cardiac reprogramming could shrink heart scar tissue, improve patients' heart function

Patients with heart failure often have a buildup of scar tissue that leads to a gradual loss of heart function. In a new study published today in the journal Cell Stem Cell, researchers from the University of North Carolina School of Medicine report significant progress toward a novel approach that could shrink the amount of heart scar tissue while replenishing the supply of healthy heart muscle.

4 Mar 2016

National Bed Month: Five tips for a perfect sleep routine

This National Bed Month Sleep Practitioner & Sleep Environment Expert James Wilson has shared his five steps to a perfect sleep routine which includes using nature’s most effective relaxant… magnesium.

From BetterYou Ltd 2 Mar 2016

Research shows nighttime lights may affect sleeping habits

If your neighborhood is well-lit at night, you may not be sleeping well, according to a study released today that will be presented at the American Academy of Neurology's 68th Annual Meeting in Vancouver, Canada, April 15 to 21, 2016.

2 Mar 2016

"Neoehrlichiosis" Internationally Diagnosed And Successfully Treated In Patients Without Immunodeficiency For The First Time

The intercellular bacteria "Candidatus Neoehrlichia", as e.g. Borrelia, can be transferred by ticks. Approx. 4.2 % of indigenous ticks are infected with this rarely explored bacterium which, until today, has been exclusively identified as pathogenic bacterium in patients with an impairment of the immune system, such as in case of leukaemia, rheumatism or after organ transplantation.

1 Mar 2016

Novartis announces FDA approval of Afinitor for progressive, nonfunctional neuroendocrine tumors of GI

Novartis today announced that the United States Food and Drug Administration approved Afinitor (everolimus) tablets for the treatment of adult patients with progressive, well-differentiated, nonfunctional neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin that are unresectable, locally advanced or metastatic.

26 Feb 2016

New ways to monitor physical activity at workplace

The science of physical activity at work remains understudied despite widespread acceptance that it plays an important role in health. Now, researchers at the Colorado School of Public Health at the University of Colorado Anschutz Medical Campus have published a comprehensive review of ways to monitor physical activity and tools for occupational exposure scientists.

26 Feb 2016

Rigel begins fostamatinib Phase 2 trial for treatment of patients with autoimmune hemolytic anemia

Rigel Pharmaceuticals Inc. today announced that it has initiated a Phase 2 clinical trial to evaluate fostamatinib, its oral SYK inhibitor, as a potential treatment for autoimmune hemolytic anemia (AIHA).

25 Feb 2016

Study: Magnesium therapy can alleviate muscular symptoms in patients with Motor Neurone Disease

Around 5,000 Motor Neurone Disease (MND) sufferers across the UK could find relief to their muscular symptoms thanks to transdermal (through the skin) magnesium therapy, say health pioneers BetterYou.

From BetterYou Ltd 25 Feb 2016

Vertical Pharmaceuticals launches breakthrough prenatal vitamin supplement: OB Complete Gold

OB Complete Gold is a breakthrough innovation in prenatal vitamin supplements that contains the advanced technology OmEGGa DHA, providing a novel egg-based DHA that comes from cage-free hens.

25 Feb 2016

Pfizer’s IBRANCE (palbociclib) now approved for use in women with HR+, HER2- metastatic breast cancer

Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication expanding the use of IBRANCE (palbociclib) 125mg capsules, Pfizer’s metastatic breast cancer therapy.

23 Feb 2016

Lucideon adds accelerated aging of UHMWPE orthopedic implants to wear and fatigue testing services

Lucideon, the international materials technology company, is pleased to announce that it has added accelerated aging of UHMWPE polymer orthopedic implants to its range of wear and fatigue testing services.

23 Feb 2016

Patients benefit from one-on-one counseling session prior to knee or hip replacement surgery

A study at Hospital for Special Surgery finds that patients benefit from a one-on-one education session provided by a physical therapist and access to a custom web portal prior to knee or hip replacement surgery.

22 Feb 2016

Briviact (brivaracetam) approved for treatment of partial onset seizures in patients with epilepsy

The U.S. Food and Drug Administration yesterday approved Briviact (brivaracetam) as an add-on treatment to other medications to treat partial onset seizures in patients age 16 years and older with epilepsy.

22 Feb 2016

Study looks at factors that affect physical recovery after participation in ultramarathon

Ultramarathon runners can expect an approximate five-to-seven-day subjective recovery post race, according to research presented this week at the Association of Academic Physiatrists Annual Meeting in Sacramento, Calif. The study also looked at factors that affect physical recovery and a runner's ability to return to full running speed after participation in an ultramarathon.

19 Feb 2016

New drug combination shows promise for patients with non-small cell lung cancer

Lung cancer is the most common cause of cancer-related death in the United States resulting in more than 158,000 deaths each year. With a 5-year survival rate at only 18 percent, the development of new and improved treatment options is needed.

18 Feb 2016

Magnesium therapy as a relaxing Mother’s day gift

This Mother’s Day, give the most important woman in your life one of the most powerful mineral relaxation rituals – magnesium therapy.

From BetterYou Ltd 17 Feb 2016

Fatigue News and Research

New FDA approval expands use of AstraZeneca's Faslodex for women with HR+, HER2- metastatic breast cancer

Kessler Foundation's Silvana L. Costa awarded Switzer Research Fellowship for research on MS

Fatigue can contribute to pitching injuries in adolescents

RUVICA (ibrutinib) capsules approved for treatment-naïve CLL patients

Cardiac reprogramming could shrink heart scar tissue, improve patients' heart function

National Bed Month: Five tips for a perfect sleep routine

Research shows nighttime lights may affect sleeping habits

"Neoehrlichiosis" Internationally Diagnosed And Successfully Treated In Patients Without Immunodeficiency For The First Time

Novartis announces FDA approval of Afinitor for progressive, nonfunctional neuroendocrine tumors of GI

New ways to monitor physical activity at workplace

Rigel begins fostamatinib Phase 2 trial for treatment of patients with autoimmune hemolytic anemia

Study: Magnesium therapy can alleviate muscular symptoms in patients with Motor Neurone Disease

Vertical Pharmaceuticals launches breakthrough prenatal vitamin supplement: OB Complete Gold

Pfizer’s IBRANCE (palbociclib) now approved for use in women with HR+, HER2- metastatic breast cancer

Lucideon adds accelerated aging of UHMWPE orthopedic implants to wear and fatigue testing services

Patients benefit from one-on-one counseling session prior to knee or hip replacement surgery

Briviact (brivaracetam) approved for treatment of partial onset seizures in patients with epilepsy

Study looks at factors that affect physical recovery after participation in ultramarathon

New drug combination shows promise for patients with non-small cell lung cancer

Magnesium therapy as a relaxing Mother’s day gift

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News